Global Ketorolac Injection Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Ketorolac Injection market report explains the definition, types, applications, major countries, and major players of the Ketorolac Injection market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Almaject

    • Pfizer

    • Virtus Pharmaceuticals

    • Sagent

    • Alvogen

    • Amphastar

    • Hikma

    • Fresenius Kabi

    • BD RX

    • Athenex

    • Fosun Pharma

    By Type:

    • 15mg/ml

    • 30mg/ml

    By End-User:

    • Hospital

    • Clinics

    • Recovery Center

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Ketorolac Injection Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Ketorolac Injection Outlook to 2028- Original Forecasts

    • 2.2 Ketorolac Injection Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Ketorolac Injection Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Ketorolac Injection Market- Recent Developments

    • 6.1 Ketorolac Injection Market News and Developments

    • 6.2 Ketorolac Injection Market Deals Landscape

    7 Ketorolac Injection Raw Materials and Cost Structure Analysis

    • 7.1 Ketorolac Injection Key Raw Materials

    • 7.2 Ketorolac Injection Price Trend of Key Raw Materials

    • 7.3 Ketorolac Injection Key Suppliers of Raw Materials

    • 7.4 Ketorolac Injection Market Concentration Rate of Raw Materials

    • 7.5 Ketorolac Injection Cost Structure Analysis

      • 7.5.1 Ketorolac Injection Raw Materials Analysis

      • 7.5.2 Ketorolac Injection Labor Cost Analysis

      • 7.5.3 Ketorolac Injection Manufacturing Expenses Analysis

    8 Global Ketorolac Injection Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Ketorolac Injection Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Ketorolac Injection Export by Region (Top 10 Countries) (2017-2028)

    9 Global Ketorolac Injection Market Outlook by Types and Applications to 2022

    • 9.1 Global Ketorolac Injection Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global 15mg/ml Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global 30mg/ml Consumption and Growth Rate (2017-2022)

    • 9.2 Global Ketorolac Injection Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Recovery Center Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Ketorolac Injection Market Analysis and Outlook till 2022

    • 10.1 Global Ketorolac Injection Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Ketorolac Injection Consumption (2017-2022)

      • 10.2.2 Canada Ketorolac Injection Consumption (2017-2022)

      • 10.2.3 Mexico Ketorolac Injection Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Ketorolac Injection Consumption (2017-2022)

      • 10.3.2 UK Ketorolac Injection Consumption (2017-2022)

      • 10.3.3 Spain Ketorolac Injection Consumption (2017-2022)

      • 10.3.4 Belgium Ketorolac Injection Consumption (2017-2022)

      • 10.3.5 France Ketorolac Injection Consumption (2017-2022)

      • 10.3.6 Italy Ketorolac Injection Consumption (2017-2022)

      • 10.3.7 Denmark Ketorolac Injection Consumption (2017-2022)

      • 10.3.8 Finland Ketorolac Injection Consumption (2017-2022)

      • 10.3.9 Norway Ketorolac Injection Consumption (2017-2022)

      • 10.3.10 Sweden Ketorolac Injection Consumption (2017-2022)

      • 10.3.11 Poland Ketorolac Injection Consumption (2017-2022)

      • 10.3.12 Russia Ketorolac Injection Consumption (2017-2022)

      • 10.3.13 Turkey Ketorolac Injection Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Ketorolac Injection Consumption (2017-2022)

      • 10.4.2 Japan Ketorolac Injection Consumption (2017-2022)

      • 10.4.3 India Ketorolac Injection Consumption (2017-2022)

      • 10.4.4 South Korea Ketorolac Injection Consumption (2017-2022)

      • 10.4.5 Pakistan Ketorolac Injection Consumption (2017-2022)

      • 10.4.6 Bangladesh Ketorolac Injection Consumption (2017-2022)

      • 10.4.7 Indonesia Ketorolac Injection Consumption (2017-2022)

      • 10.4.8 Thailand Ketorolac Injection Consumption (2017-2022)

      • 10.4.9 Singapore Ketorolac Injection Consumption (2017-2022)

      • 10.4.10 Malaysia Ketorolac Injection Consumption (2017-2022)

      • 10.4.11 Philippines Ketorolac Injection Consumption (2017-2022)

      • 10.4.12 Vietnam Ketorolac Injection Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Ketorolac Injection Consumption (2017-2022)

      • 10.5.2 Colombia Ketorolac Injection Consumption (2017-2022)

      • 10.5.3 Chile Ketorolac Injection Consumption (2017-2022)

      • 10.5.4 Argentina Ketorolac Injection Consumption (2017-2022)

      • 10.5.5 Venezuela Ketorolac Injection Consumption (2017-2022)

      • 10.5.6 Peru Ketorolac Injection Consumption (2017-2022)

      • 10.5.7 Puerto Rico Ketorolac Injection Consumption (2017-2022)

      • 10.5.8 Ecuador Ketorolac Injection Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Ketorolac Injection Consumption (2017-2022)

      • 10.6.2 Kuwait Ketorolac Injection Consumption (2017-2022)

      • 10.6.3 Oman Ketorolac Injection Consumption (2017-2022)

      • 10.6.4 Qatar Ketorolac Injection Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Ketorolac Injection Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Ketorolac Injection Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Ketorolac Injection Consumption (2017-2022)

      • 10.7.2 South Africa Ketorolac Injection Consumption (2017-2022)

      • 10.7.3 Egypt Ketorolac Injection Consumption (2017-2022)

      • 10.7.4 Algeria Ketorolac Injection Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Ketorolac Injection Consumption (2017-2022)

      • 10.8.2 New Zealand Ketorolac Injection Consumption (2017-2022)

    11 Global Ketorolac Injection Competitive Analysis

    • 11.1 Almaject

      • 11.1.1 Almaject Company Details

      • 11.1.2 Almaject Ketorolac Injection Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Almaject Ketorolac Injection Main Business and Markets Served

      • 11.1.4 Almaject Ketorolac Injection Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Pfizer

      • 11.2.1 Pfizer Company Details

      • 11.2.2 Pfizer Ketorolac Injection Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Pfizer Ketorolac Injection Main Business and Markets Served

      • 11.2.4 Pfizer Ketorolac Injection Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Virtus Pharmaceuticals

      • 11.3.1 Virtus Pharmaceuticals Company Details

      • 11.3.2 Virtus Pharmaceuticals Ketorolac Injection Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Virtus Pharmaceuticals Ketorolac Injection Main Business and Markets Served

      • 11.3.4 Virtus Pharmaceuticals Ketorolac Injection Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Sagent

      • 11.4.1 Sagent Company Details

      • 11.4.2 Sagent Ketorolac Injection Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Sagent Ketorolac Injection Main Business and Markets Served

      • 11.4.4 Sagent Ketorolac Injection Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Alvogen

      • 11.5.1 Alvogen Company Details

      • 11.5.2 Alvogen Ketorolac Injection Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Alvogen Ketorolac Injection Main Business and Markets Served

      • 11.5.4 Alvogen Ketorolac Injection Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Amphastar

      • 11.6.1 Amphastar Company Details

      • 11.6.2 Amphastar Ketorolac Injection Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Amphastar Ketorolac Injection Main Business and Markets Served

      • 11.6.4 Amphastar Ketorolac Injection Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Hikma

      • 11.7.1 Hikma Company Details

      • 11.7.2 Hikma Ketorolac Injection Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Hikma Ketorolac Injection Main Business and Markets Served

      • 11.7.4 Hikma Ketorolac Injection Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Fresenius Kabi

      • 11.8.1 Fresenius Kabi Company Details

      • 11.8.2 Fresenius Kabi Ketorolac Injection Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Fresenius Kabi Ketorolac Injection Main Business and Markets Served

      • 11.8.4 Fresenius Kabi Ketorolac Injection Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 BD RX

      • 11.9.1 BD RX Company Details

      • 11.9.2 BD RX Ketorolac Injection Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 BD RX Ketorolac Injection Main Business and Markets Served

      • 11.9.4 BD RX Ketorolac Injection Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Athenex

      • 11.10.1 Athenex Company Details

      • 11.10.2 Athenex Ketorolac Injection Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Athenex Ketorolac Injection Main Business and Markets Served

      • 11.10.4 Athenex Ketorolac Injection Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Fosun Pharma

      • 11.11.1 Fosun Pharma Company Details

      • 11.11.2 Fosun Pharma Ketorolac Injection Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Fosun Pharma Ketorolac Injection Main Business and Markets Served

      • 11.11.4 Fosun Pharma Ketorolac Injection Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    12 Global Ketorolac Injection Market Outlook by Types and Applications to 2028

    • 12.1 Global Ketorolac Injection Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global 15mg/ml Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global 30mg/ml Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Ketorolac Injection Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Recovery Center Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Ketorolac Injection Market Analysis and Outlook to 2028

    • 13.1 Global Ketorolac Injection Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.2.2 Canada Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Ketorolac Injection Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.3.2 UK Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.3.3 Spain Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.3.5 France Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.3.6 Italy Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.3.8 Finland Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.3.9 Norway Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.3.11 Poland Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.3.12 Russia Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Ketorolac Injection Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.4.2 Japan Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.4.3 India Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Ketorolac Injection Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.5.3 Chile Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.5.6 Peru Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Ketorolac Injection Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.6.3 Oman Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Ketorolac Injection Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Ketorolac Injection Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Ketorolac Injection Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Ketorolac Injection Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Ketorolac Injection

    • Figure of Ketorolac Injection Picture

    • Table Global Ketorolac Injection Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Ketorolac Injection Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global 15mg/ml Consumption and Growth Rate (2017-2022)

    • Figure Global 30mg/ml Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Recovery Center Consumption and Growth Rate (2017-2022)

    • Figure Global Ketorolac Injection Consumption by Country (2017-2022)

    • Table North America Ketorolac Injection Consumption by Country (2017-2022)

    • Figure United States Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Canada Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Mexico Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Table Europe Ketorolac Injection Consumption by Country (2017-2022)

    • Figure Germany Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure UK Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Spain Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Belgium Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure France Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Italy Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Denmark Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Finland Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Norway Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Sweden Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Poland Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Russia Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Turkey Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Table APAC Ketorolac Injection Consumption by Country (2017-2022)

    • Figure China Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Japan Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure India Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure South Korea Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Thailand Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Singapore Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Philippines Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Table South America Ketorolac Injection Consumption by Country (2017-2022)

    • Figure Brazil Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Colombia Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Chile Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Argentina Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Peru Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Table GCC Ketorolac Injection Consumption by Country (2017-2022)

    • Figure Bahrain Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Oman Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Qatar Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Table Africa Ketorolac Injection Consumption by Country (2017-2022)

    • Figure Nigeria Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure South Africa Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Egypt Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure Algeria Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Table Oceania Ketorolac Injection Consumption by Country (2017-2022)

    • Figure Australia Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Ketorolac Injection Consumption and Growth Rate (2017-2022)

    • Table Almaject Company Details

    • Table Almaject Ketorolac Injection Sales, Price, Value and Gross Profit (2017-2022)

    • Table Almaject Ketorolac Injection Main Business and Markets Served

    • Table Almaject Ketorolac Injection Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Ketorolac Injection Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Ketorolac Injection Main Business and Markets Served

    • Table Pfizer Ketorolac Injection Product Portfolio

    • Table Virtus Pharmaceuticals Company Details

    • Table Virtus Pharmaceuticals Ketorolac Injection Sales, Price, Value and Gross Profit (2017-2022)

    • Table Virtus Pharmaceuticals Ketorolac Injection Main Business and Markets Served

    • Table Virtus Pharmaceuticals Ketorolac Injection Product Portfolio

    • Table Sagent Company Details

    • Table Sagent Ketorolac Injection Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sagent Ketorolac Injection Main Business and Markets Served

    • Table Sagent Ketorolac Injection Product Portfolio

    • Table Alvogen Company Details

    • Table Alvogen Ketorolac Injection Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alvogen Ketorolac Injection Main Business and Markets Served

    • Table Alvogen Ketorolac Injection Product Portfolio

    • Table Amphastar Company Details

    • Table Amphastar Ketorolac Injection Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amphastar Ketorolac Injection Main Business and Markets Served

    • Table Amphastar Ketorolac Injection Product Portfolio

    • Table Hikma Company Details

    • Table Hikma Ketorolac Injection Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hikma Ketorolac Injection Main Business and Markets Served

    • Table Hikma Ketorolac Injection Product Portfolio

    • Table Fresenius Kabi Company Details

    • Table Fresenius Kabi Ketorolac Injection Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fresenius Kabi Ketorolac Injection Main Business and Markets Served

    • Table Fresenius Kabi Ketorolac Injection Product Portfolio

    • Table BD RX Company Details

    • Table BD RX Ketorolac Injection Sales, Price, Value and Gross Profit (2017-2022)

    • Table BD RX Ketorolac Injection Main Business and Markets Served

    • Table BD RX Ketorolac Injection Product Portfolio

    • Table Athenex Company Details

    • Table Athenex Ketorolac Injection Sales, Price, Value and Gross Profit (2017-2022)

    • Table Athenex Ketorolac Injection Main Business and Markets Served

    • Table Athenex Ketorolac Injection Product Portfolio

    • Table Fosun Pharma Company Details

    • Table Fosun Pharma Ketorolac Injection Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fosun Pharma Ketorolac Injection Main Business and Markets Served

    • Table Fosun Pharma Ketorolac Injection Product Portfolio

    • Figure Global 15mg/ml Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 30mg/ml Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Recovery Center Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ketorolac Injection Consumption Forecast by Country (2022-2028)

    • Table North America Ketorolac Injection Consumption Forecast by Country (2022-2028)

    • Figure United States Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Ketorolac Injection Consumption Forecast by Country (2022-2028)

    • Figure Germany Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Ketorolac Injection Consumption Forecast by Country (2022-2028)

    • Figure China Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Ketorolac Injection Consumption Forecast by Country (2022-2028)

    • Figure Brazil Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Ketorolac Injection Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Ketorolac Injection Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Ketorolac Injection Consumption Forecast by Country (2022-2028)

    • Figure Australia Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Ketorolac Injection Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.